John Paul Taylor

Summary

Affiliation: University of Newcastle
Country: UK

Publications

  1. ncbi Neuroimaging of dementia with Lewy bodies
    John Paul Taylor
    Institute for Ageing and Health, Wolfson Research Centre, Campus for Aging and Vitality, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK
    Neuroimaging Clin N Am 22:67-81, viii. 2012
  2. ncbi Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies
    John Paul Taylor
    Institute for Ageing and Health, Wolfson Research Centre, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne NE4 6BE, UK
    J Neurol Neurosurg Psychiatry 78:1069-71. 2007
  3. ncbi Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotype
    J P Taylor
    Institute for Ageing and Health, Wolfson Research Centre, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne NE4 6BE, UK
    J Neurol Neurosurg Psychiatry 79:1318-23. 2008
  4. ncbi Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study
    John Paul Taylor
    Institute for Ageing and Health, Newcastle University, Wolfson Research Centre, Campus for Ageing and Vitality, Newcastle upon Tyne NE4 5PL, UK
    Br J Psychiatry 199:492-500. 2011
  5. ncbi Development of a novel FMRI compatible visual perception prototype battery to test older people with and without dementia
    Joshua S Wood
    Institute for Cellular Medicine, Newcastle Magnetic Resonance Centre, Newcastle University, Newcastle upon Tyne, UK
    J Geriatr Psychiatry Neurol 24:73-83. 2011

Detail Information

Publications5

  1. ncbi Neuroimaging of dementia with Lewy bodies
    John Paul Taylor
    Institute for Ageing and Health, Wolfson Research Centre, Campus for Aging and Vitality, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK
    Neuroimaging Clin N Am 22:67-81, viii. 2012
    ..Imaging research on DLB has had significant ramifications in terms of raising the profile of DLB and helping define it as a distinctive and separate disease entity from AD...
  2. ncbi Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies
    John Paul Taylor
    Institute for Ageing and Health, Wolfson Research Centre, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne NE4 6BE, UK
    J Neurol Neurosurg Psychiatry 78:1069-71. 2007
    ..As ChEi are frequently used in people with dementia, it is important to determine whether their use affects 123I-FP-CIT uptake in the striatum...
  3. ncbi Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotype
    J P Taylor
    Institute for Ageing and Health, Wolfson Research Centre, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne NE4 6BE, UK
    J Neurol Neurosurg Psychiatry 79:1318-23. 2008
    ..People with PD display attentional deficits; however, it is not clear whether attentional deficits in patients with non-demented PD are associated with (i) PIGD phenotype and/or (ii) subsequent cognitive decline...
  4. ncbi Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study
    John Paul Taylor
    Institute for Ageing and Health, Newcastle University, Wolfson Research Centre, Campus for Ageing and Vitality, Newcastle upon Tyne NE4 5PL, UK
    Br J Psychiatry 199:492-500. 2011
    ..The aetiology of visual hallucinations is poorly understood in dementia with Lewy bodies. Pathological alterations in visual cortical excitability may be one contributory mechanism...
  5. ncbi Development of a novel FMRI compatible visual perception prototype battery to test older people with and without dementia
    Joshua S Wood
    Institute for Cellular Medicine, Newcastle Magnetic Resonance Centre, Newcastle University, Newcastle upon Tyne, UK
    J Geriatr Psychiatry Neurol 24:73-83. 2011
    ..We aimed to develop, pilot, and test a novel visuocognitive prototype test battery which addressed these issues, suitable for both clinical and functional imaging use...